SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the December 2024 quarter moved down to Rs. 342.33 millions as compared to Rs. 371.35 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -69.74 millions as compared to Net Loss of Rs. -161.67 millions of corresponding quarter ended December 2023Operating profit Margin for the quarter ended December 2024 slipped to -1.76% as compared to 9.21% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 342.33 371.35 -7.81 810.29 1004.11 -19.30 1367.97 1768.25 -22.64
Other Income 0.03 0.37 -91.89 0.33 22.03 -98.50 95.72 2.39 3905.02
PBIDT -1.76 9.21 -119.11 -120.07 -26.14 359.33 -182.39 -1879.36 -90.30
Interest 4.31 131.57 -96.72 10.55 355.95 -97.04 19.04 352.80 -94.60
PBDT -6.07 -122.36 -95.04 -130.62 -382.09 -65.81 -259.72 -2232.16 -88.36
Depreciation 63.67 44.85 41.96 140.19 134.55 4.19 184.10 1069.10 -82.78
PBT -69.74 -167.21 -58.29 -270.81 -516.64 -47.58 -443.82 -3301.26 -86.56
TAX 0.00 -5.54 0.00 0.00 -5.54 0.00 0.00 -21.17 0.00
Deferred Tax 0.00 -5.54 0.00 0.00 -5.54 0.00 0.00 -21.17 0.00
PAT -69.74 -161.67 -56.86 -270.81 -511.10 -47.01 -443.82 -3280.09 -86.47
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) -0.51 2.48 -120.73 -14.82 -2.60 469.21 -13.33 -106.28 -87.46

Vivimed Labs Share Price

7.06 0.33 (4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×